Tradestie Institutional Equity Comparison Engine

GNPX vs NNVC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

NNVC Overall Edge

NNVC Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“0 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to NanoViricides Inc. (NNVC) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, GNPX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NNVC at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, GNPX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against NNVC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
GNPX N/M vs NNVC N/M Fwd P/E
Growth & Margin Winner NNVC
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner NNVC
1Y -56.6% vs -19.1% ยท 52W Pos 11% vs 27%
Options & Structure Winner NNVC
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
GNPX NASDAQ
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap $2.2M
1M Return -26.77%
1Y Return -56.59%
Forward P/E N/M
Unified AI Score
42.2 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 50.0 Mom 59.0
NNVC NYSE American
NanoViricides Inc.
Pharmaceutical Preparations
$1.14
-2.56% 1D
Market Cap $29.9M
1M Return -17.99%
1Y Return -19.15%
Forward P/E N/M
Unified AI Score
48.1 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 60.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GNPX -56.59% NNVC -19.15% Spread: +37.44 pp (NNVC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
GNPX TTM Op. Margin: 0.0% NNVC TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNPX vs NNVC. Trailing 12-month operating profitability (GNPX 0.0% vs NNVC 0.0%) and valuation multiples (GNPX N/M vs NNVC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GNPX (0) vs NNVC (5)
Institutional Metric GNPX NNVC Criterion Row Winner
Market Capitalization Scale $2.2M $29.9M Larger Scale NNVC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -233.7% -179.2% Higher ROE NNVC
52-Week Range Position Momentum 11% ($0โ€“$10) 27% ($1โ€“$2) Stronger Trend NNVC
Beta / 30D Volatility Risk Regime -4.68ฮฒ ยท 96% Vol 1.95ฮฒ ยท 69% Vol Lower Realized Risk NNVC
Unified Institutional Score Composite Signal 42.2 / 100 (HOLD) 48.1 / 100 (HOLD) Higher Composite NNVC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GNPX vs NNVC Buy Guide
GNPX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live GNPX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NNVC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live NNVC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GNPX nor NNVC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.